{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:16:52Z","timestamp":1788812212042,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111525","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T18:43:44Z","timestamp":1618771424000},"page":"111525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model"],"prefix":"10.1016","volume":"139","author":[{"given":"Anjana","family":"Pathania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Sandhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111525_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2021.111525_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2021.111525_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40263-015-0249-8","article-title":"Defining the role of the monoamine oxidase-B inhibitors for Parkinson\u2019s disease","volume":"29","author":"Robakis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2021.111525_bib4","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1074\/jbc.M006972200","article-title":"Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid","volume":"276","author":"Geha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111525_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2011.20.1.1","article-title":"MAO-inhibitors in Parkinson\u2019s disease","volume":"20","author":"Riederer","year":"2011","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.biopha.2021.111525_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111525_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/0091270011406279","article-title":"The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111525_bib8","first-page":"467","article-title":"Rasagiline \u2013 a novel MAO B inhibitor in Parkinson\u2019s disease therapy","volume":"3","author":"Lecht","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.biopha.2021.111525_bib9","first-page":"18","article-title":"Hydroxytyrosol and potential uses in cardiovascular diseases, cancer, and AIDS","volume":"1","author":"Vilaplana-P\u00e9rez","year":"2014","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2021.111525_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/medicines5010013","article-title":"Hydroxytyrosol: health benefits and use as functional ingredient in meat","volume":"5","author":"Mart\u00ednez","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.biopha.2021.111525_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/ijms18050930","article-title":"Hydroxytyrosol and cytoprotection: a projection for clinical interventions","volume":"18","author":"Echeverr\u00eda","year":"2017","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2021.111525_bib12","first-page":"1477","article-title":"Cardioprotective effects of the polyphenol hydroxytyrosol from olive oil","volume":"18","author":"Tejada","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2021.111525_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/01635581.2017.1339818","article-title":"Hydroxytyrosol induces apoptosis and cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells","volume":"69","author":"Zubair","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2021.111525_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fmicb.2019.00390","article-title":"Hydroxytyrosol improves obesity and insulin resistance by modulating gut microbiota in high-fat diet-induced obese mice","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.111525_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5650\/jos.ess15026","article-title":"The \u03b1-glucosidase and \u03b1-amylase enzyme inhibitory of hydroxytyrosol and oleuropein","volume":"64","author":"Hadrich","year":"2015","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.biopha.2021.111525_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106434","article-title":"Modulating A\u03b2 aggregation by tyrosol-based ligands: the crucial role of the catechol moiety","volume":"265","author":"Romanucci","year":"2020","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.biopha.2021.111525_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113722","article-title":"Insight into the molecular mechanism underlying the inhibition of \u03b1-synuclein aggregation by hydroxytyrosol","volume":"173","author":"Palazzi","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111525_bib18","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1096\/fj.201902643R","article-title":"Hydroxytyrosol stimulates neurogenesis in aged dentate gyrus by enhancing stem and progenitor cell proliferation and neuron survival","volume":"34","author":"D\u2019Andrea","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.111525_bib19","unstructured":"R. Crea, Treatment of Early Stage Parkinsons Disease with a Hydroxytyrosol-Containing Polyphenol Formulation, US 20160374959A1, 2016."},{"key":"10.1016\/j.biopha.2021.111525_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fncel.2018.00373","article-title":"Phenolic compounds characteristic of the mediterranean diet in mitigating microglia-mediated neuroinflammation","volume":"12","author":"Hornedo-Ortega","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111525_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21113893","article-title":"Healthspan enhancement by olive polyphenols in C. elegans wild type and parkinson\u2019s models","volume":"21","author":"Di Rosa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111525_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.freeradbiomed.2003.12.003","article-title":"An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury","volume":"36","author":"Hashimoto","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111525_bib23","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11064-016-1959-0","article-title":"3,4-Dihydroxyphenylethanol (hydroxytyrosol) mitigates the increase in spontaneous oxidation of dopamine during monoamine oxidase inhibition in PC12 cells","volume":"41","author":"Goldstein","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111525_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9090824","article-title":"Anti-inflammatory and anti-oxidant activity of hidrox\u00ae in rotenone-induced Parkinson\u2019s disease in mice","volume":"9","author":"Siracusa","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2021.111525_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jnutbio.2014.12.013","article-title":"Role of the catechol group in the antioxidant and neuroprotective effects of virgin olive oil components in rat brain","volume":"26","author":"De La Cruz","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2021.111525_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2741\/s538","article-title":"Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ in vivo","volume":"12","author":"Perez-Barron","year":"2020","journal-title":"Front. Biosci. (Sch. Ed.)"},{"key":"10.1016\/j.biopha.2021.111525_bib27","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.111525_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm101359c","article-title":"Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex","volume":"54","author":"Binda","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111525_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/07391102.2015.1064830","article-title":"Evaluation of potential flavonoid inhibitors of glyoxalase-I based on virtual screening and in vitro studies","volume":"34","author":"Yadav","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.biopha.2021.111525_bib30","unstructured":"Schr\u00f6dinger Release 2020\u20131, LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.biopha.2021.111525_bib31","first-page":"1","article-title":"Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors","author":"Uniyal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.biopha.2021.111525_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.biopha.2021.111525_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2021.111525_bib34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform: an Alzheimer\u2019s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Liu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2021.111525_bib35","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/molecules24132392","article-title":"Synthesis and AChE inhibitory activity of novel thiazolylhydrazone derivatives","volume":"24","author":"Osmaniye","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111525_bib36","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111525_bib37","doi-asserted-by":"crossref","unstructured":"K.J. Bowers, E. Chow, H. Xu, R.O. Dror, M.P. Eastwood, B.A. Gregersen, J.L. Klepeis, I. Kolossvary, M.A. Moraes, F.D. Sacerdoti, J.K. Salmon, Y. Shan, D.E. Shaw, Scalable algorithms for molecular dynamics simulations on commodity clusters, in: Proceedings of the ACM\/IEEE Supercomputing Conference, 2006, p. 84.","DOI":"10.1145\/1188455.1188544"},{"key":"10.1016\/j.biopha.2021.111525_bib38","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.biopha.2021.111525_bib39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/alcalc\/37.6.566","article-title":"Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender","volume":"37","author":"Coccini","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.biopha.2021.111525_bib40","first-page":"1","article-title":"Dynamic changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson\u2019s disease","volume":"2017","author":"Huang","year":"2017","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.biopha.2021.111525_bib41","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1017\/S0007114515000884","article-title":"Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of db\/db mice: role of AMP-activated protein kinase activation","volume":"113","author":"Zheng","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2021.111525_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-3806(00)00111-5","article-title":"Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury","volume":"125","author":"Puka-Sundvall","year":"2000","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.biopha.2021.111525_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.physbeh.2014.02.036","article-title":"Antidepressant effects of insulin in streptozotocin induced diabetic mice: modulation of brain serotonin system","volume":"129","author":"Gupta","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2021.111525_bib44","first-page":"A36","article-title":"Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors","volume":"3","author":"Church","year":"2005","journal-title":"J. Undergrad. Neurosci. Educ."},{"key":"10.1016\/j.biopha.2021.111525_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0028-3908(82)90032-6","article-title":"Neurotensin induces catalepsy in mice","volume":"21","author":"Snuders","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111525_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0812s15","article-title":"Motor coordination and balance in rodents","volume":"15","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.biopha.2021.111525_bib47","first-page":"52434","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"6","author":"Seibenhener","year":"2015","journal-title":"JoVE"},{"key":"10.1016\/j.biopha.2021.111525_bib48","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1074\/jbc.M500949200","article-title":"Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors","volume":"280","author":"Hub\u00e1lek","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111525_bib49","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1016\/j.bmcl.2005.07.043","article-title":"Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (Ki) of a series of experimentally tested compounds","volume":"15","author":"Toprak\u00e7\u00ed","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2021.111525_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0893-133X(98)00075-X","article-title":"Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression","volume":"20","author":"Lotufo-Neto","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2021.111525_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnagi.2014.00180","article-title":"Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson\u2019s disease","volume":"6","author":"Krishna","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2021.111525_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-386467-3.00009-1","article-title":"Selective inhibitors of monoamine oxidase type B and the \u201ccheese effect\u201d","author":"Finberg","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2021.111525_bib53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11030-013-9490-6","article-title":"Selective MAO-B inhibitors: a lesson from natural products","volume":"18","author":"Carradori","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.biopha.2021.111525_bib54","unstructured":"Forum on Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Institute of Medicine. Improving and Accelerating Therapeutic Development for Nervous System Disorders: Workshop Summary. Washington (DC): National Academies Press (US), 2014, 2, Drug Development Challenges."},{"key":"10.1016\/j.biopha.2021.111525_bib55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00394-020-02295-0","article-title":"Pharmacokinetics and bioavailability of hydroxytyrosol are dependent on the food matrix in humans","volume":"60","author":"Alem\u00e1n-Jim\u00e9nez","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.biopha.2021.111525_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)01216-3","article-title":"Olive oil phenolics are dose-dependently absorbed in humans","volume":"468","author":"Visioli","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2021.111525_bib57","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jn\/131.7.1993","article-title":"The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats","volume":"131","author":"Tuck","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.111525_bib58","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5498\/wjp.v2.i6.124","article-title":"Platelets: a possible glance into brain biological processes in schizophrenia","volume":"2","author":"Asor","year":"2012","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111525_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1471-4159.1993.tb03554.x","article-title":"The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical","volume":"61","author":"Chen","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111525_bib60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.179.4076.916","article-title":"Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia","volume":"179","author":"Wyatt","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111525_bib61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.53.10.854","article-title":"Platelet monoamine oxidase B activity in Parkinsonian patients","volume":"53","author":"Bonuccelli","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111525_bib62","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4103\/1673-5374.189201","article-title":"No synergism between bis(Propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson\u2019s disease mice","volume":"11","author":"Zheng","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2021.111525_bib63","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.chroma.2008.10.116","article-title":"Measurement of free hydroxytyrosol in microdialysates from blood and brain of anesthetized rats by liquid chromatography with fluorescence detection","volume":"1216","author":"Wu","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2021.111525_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jff.2016.02.046","article-title":"Human hydroxytyrosol\u2019s absorption and excretion from a nutraceutical","volume":"23","author":"Khymenets","year":"2016","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.biopha.2021.111525_bib65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jff.2018.04.028","article-title":"Brain uptake of hydroxytyrosol and its main circulating metabolites: protective potential in neuronal cells","volume":"46","author":"de las Hazas","year":"2018","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.biopha.2021.111525_bib66","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/C7FO00090A","article-title":"Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-\u03b1 and Nrf2 activation, and NF-\u03baB down-regulation","volume":"8","author":"Valenzuela","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2021.111525_bib67","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.biopha.2018.11.120","article-title":"Hydroxytyrosol supplementation ameliorates the metabolic disturbances in white adipose tissue from mice fed a high-fat diet through recovery of transcription factors Nrf2, SREBP-1c, PPAR-\u03b3 and NF-\u03baB","volume":"109","author":"Illesca","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111525_bib68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12944-017-0450-5","article-title":"Hydroxytyrosol prevents reduction in liver activity of \u0394-5 and \u0394-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice","volume":"16","author":"Valenzuela","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2021.111525_bib69","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/brain\/awx172","article-title":"Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders","volume":"140","author":"Tong","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2021.111525_bib70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11481-012-9363-2","article-title":"Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the mptp model of Parkinson\u2019s disease","volume":"7","author":"Ojha","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.biopha.2021.111525_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.biopha.2021.111525_bib72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archneurpsyc.1938.02270010024002","article-title":"Vesical activity in schizophrenic states associated with catalepsy","volume":"39","author":"Tauber","year":"1938","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111525_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12640-014-9492-x","article-title":"3,4-Dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer\u2019s disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs","volume":"27","author":"Arunsundar","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2021.111525_bib74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jnutbio.2014.10.006","article-title":"Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspring","volume":"26","author":"Zheng","year":"2015","journal-title":"J. Nutr. Biochem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:24:46Z","timestamp":1760099086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":74,"alternative-id":["S0753332221003103"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111525","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111525"}}